Rock Creek Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-27
Closed -$6.64K 112
2023
Q3
$6.64K Buy
+27
New +$7.39K ﹤0.01% 181
2022
Q3
Sell
-42
Closed -$7K 176
2022
Q2
$7K Hold
42
﹤0.01% 154
2022
Q1
$11K Buy
42
+11
+35% +$2.76K ﹤0.01% 157
2021
Q4
$8K Buy
31
+19
+158% +$4.65K ﹤0.01% 204
2021
Q3
$3K Sell
12
-8
-40% -$1.96K ﹤0.01% 177
2021
Q2
$4K Sell
20
-6
-23% -$1.22K ﹤0.01% 179
2021
Q1
$5K Sell
26
-91
-78% -$16K ﹤0.01% 200
2020
Q4
$19K Buy
+117
New +$17.1K 0.01% 164
2020
Q3
Sell
-453
Closed -$44K 199
2020
Q2
$44K Sell
453
-4,303
-90% -$447K 0.02% 178
2020
Q1
$427K Sell
4,756
-666
-12% -$86.2K 0.24% 79
2019
Q4
$800K Buy
5,422
+308
+6% +$41.4K 0.32% 69
2019
Q3
$616K Buy
5,114
+295
+6% +$38.1K 0.29% 75
2019
Q2
$651K Buy
+4,819
New +$609K 0.3% 71

Other funds holding HCA

Rock Creek Group's HCA Position: Q4 2023 in Review

Rock Creek Group sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 27 shares — an estimated $6.64K sold.

Rock Creek Group first reported a position in HCA in Q2 2019 and held it in 13 quarters. The position peaked at $800K in Q4 2019. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Rock Creek Group reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
  • Rock Creek Group sold 27 HCA Healthcare shares in Q4 2023, an estimated $6.64K.
  • Rock Creek Group first reported a position in HCA Healthcare in Q2 2019 and held it in 13 quarters.
  • Rock Creek Group's HCA Healthcare position peaked at $800K in Q4 2019.
  • 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.